Zacks: Analysts Anticipate Danaher Co. (DHR) Will Announce Quarterly Sales of $5.32 Billion

Brokerages expect that Danaher Co. (NYSE:DHR) will announce sales of $5.32 billion for the current quarter, Zacks reports. Six analysts have issued estimates for Danaher’s earnings, with estimates ranging from $5.26 billion to $5.41 billion. Danaher posted sales of $5.09 billion during the same quarter last year, which would indicate a positive year over year growth rate of 4.5%. The company is scheduled to report its next earnings report on Tuesday, January 29th.

On average, analysts expect that Danaher will report full year sales of $19.84 billion for the current financial year, with estimates ranging from $19.79 billion to $19.93 billion. For the next fiscal year, analysts expect that the business will report sales of $20.54 billion, with estimates ranging from $20.15 billion to $20.79 billion. Zacks’ sales calculations are an average based on a survey of sell-side analysts that follow Danaher.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Thursday, October 18th. The conglomerate reported $1.10 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.07 by $0.03. The business had revenue of $4.85 billion during the quarter, compared to analyst estimates of $4.80 billion. Danaher had a net margin of 14.07% and a return on equity of 11.59%. The firm’s quarterly revenue was up 7.2% on a year-over-year basis. During the same quarter last year, the business earned $1.00 EPS.

DHR has been the subject of a number of research reports. Zacks Investment Research upgraded shares of Danaher from a “hold” rating to a “buy” rating and set a $119.00 price objective for the company in a report on Wednesday, September 19th. Morgan Stanley raised their price target on shares of Danaher from $122.00 to $126.00 and gave the stock an “overweight” rating in a report on Wednesday, October 10th. Finally, Robert W. Baird lowered their price target on shares of Danaher from $116.00 to $114.00 and set an “outperform” rating for the company in a report on Friday, October 19th. One investment analyst has rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus price target of $112.14.

In other news, CFO Daniel L. Comas sold 36,000 shares of Danaher stock in a transaction on Thursday, November 8th. The shares were sold at an average price of $103.88, for a total value of $3,739,680.00. Following the completion of the sale, the chief financial officer now owns 124,218 shares in the company, valued at approximately $12,903,765.84. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Donald J. Ehrlich sold 10,578 shares of Danaher stock in a transaction on Tuesday, October 23rd. The shares were sold at an average price of $95.77, for a total transaction of $1,013,055.06. Following the completion of the sale, the director now owns 105,491 shares of the company’s stock, valued at approximately $10,102,873.07. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 150,007 shares of company stock valued at $15,202,163. Company insiders own 11.90% of the company’s stock.

Large investors have recently added to or reduced their stakes in the company. Fort L.P. bought a new stake in shares of Danaher in the 2nd quarter valued at $119,000. Braun Bostich & Associates Inc. grew its position in Danaher by 506.4% in the 2nd quarter. Braun Bostich & Associates Inc. now owns 1,225 shares of the conglomerate’s stock valued at $121,000 after purchasing an additional 1,023 shares during the period. Belpointe Asset Management LLC acquired a new stake in Danaher in the 3rd quarter valued at $121,000. Reilly Financial Advisors LLC grew its position in Danaher by 62.6% in the 3rd quarter. Reilly Financial Advisors LLC now owns 1,301 shares of the conglomerate’s stock valued at $141,000 after purchasing an additional 501 shares during the period. Finally, Sun Life Financial INC grew its position in Danaher by 508.4% in the 2nd quarter. Sun Life Financial INC now owns 1,667 shares of the conglomerate’s stock valued at $164,000 after purchasing an additional 1,393 shares during the period. Institutional investors own 77.13% of the company’s stock.

Shares of NYSE DHR opened at $101.87 on Friday. The company has a market capitalization of $74.51 billion, a P/E ratio of 25.28, a price-to-earnings-growth ratio of 2.05 and a beta of 1.06. Danaher has a 1 year low of $91.84 and a 1 year high of $110.86. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.53 and a quick ratio of 1.08.

The company also recently declared a quarterly dividend, which will be paid on Friday, January 25th. Shareholders of record on Friday, December 28th will be issued a dividend of $0.16 per share. The ex-dividend date of this dividend is Thursday, December 27th. This represents a $0.64 annualized dividend and a yield of 0.63%. Danaher’s payout ratio is 15.88%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.

Read More: Cash Flow

Get a free copy of the Zacks research report on Danaher (DHR)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply